Related Experiment Video
Updated: May 29, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Considerations for safety pharmacogenetics in clinical practice.
1Medco Research Institute, LLC, 7315 Wisconsin Avenue, Bethesda, USA. felix_frueh@medco.com
Drug Discovery Today
|October 4, 2011
Summary
Personalized medicine uses patient characteristics and pharmacogenetics for tailored treatments. However, assessing individual safety risks, especially through safety pharmacogenetics, requires more rigorous evaluation and application.
Area of Science:
- Pharmacogenomics and Precision Medicine
- Clinical Diagnostics and Patient Assessment
Background:
- Individualized patient treatment requires understanding specific needs through health assessments.
- Biomarkers and phenotypic/molecular characteristics deepen treatment insights.
- Pharmacogenetics is increasingly integrated into patient assessments for personalized medicine.
Purpose of the Study:
- To highlight the importance of assessing individual patient safety risks in personalized medicine.
- To emphasize the gap in rigorous safety risk evaluation compared to treatment efficacy.
- To advocate for the broader application of safety pharmacogenetics.
Main Methods:
- Review of current practices in patient assessment and personalized medicine.
- Analysis of how genetic variations and environmental factors influence treatment.
- Examination of information dissemination regarding treatment safety risks.
Main Results:
- Personalized medicine heavily relies on genetic and environmental factors for treatment efficacy.
- Safety risk communication is often generalized, lacking individual patient-specific data.
- Safety pharmacogenetic tests exist but are underutilized.
Conclusions:
- A more rigorous approach to assessing individual safety risks is needed in personalized medicine.
- Increased utilization of safety pharmacogenetics can improve patient safety.
- Bridging the gap between efficacy and safety assessment is crucial for true personalized care.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...